PATENT CLAIM ANALYSIS

Application Number: 15969500
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "653000"]

Abstract:
Pharmaceutical compositions comprising epinephrine, methods of administration, and methods of making the same. Compositions may comprise at least one of an active agent, a pH raising agent, an antioxidant, a transition metal complexing agent, a pH lowering agent, a tonicity regulating agent, optionally a preservative, and optionally a solvent.

Claim (Index 19):
A composition consisting of:\n epinephrine and/or salts thereof at a concentration of 0.114 mg/mL, a tonicity regulating agent comprising sodium chloride at a concentration of 9 mg/mL, a pH raising agent comprising tartaric acid at a concentration of 0.225 mg/mL and sodium hydroxide at a concentration of 0.1 mg/mL, an antioxidant comprising sodium metabisulfite at a concentration of 0.0457 mg/mL, a pH lowering agent comprising hydrochloric acid at a concentration of 0.025 mg/mL, a transition metal complexing agent comprising EDTA at a concentration of 0.02 mg/mL, and water.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 93.0
- Lexical Diversity: 1.71429
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14657990', '14818121', '14863112', '13824132', '13828148']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7321342208717434
- 35 USC 102 Novelty (BERT): 0.5295927946748982
- Combined Prediction Score: 0.7118800782520589
- Mean Citation Score: 273.301836
- Max Citation Score: 331.1929
- Similarity Product: 243.07747569865583

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test